-transparent.png){kind=logo}
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. 1976
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
Twenty-three patients with metastatic non-oat cell bronchogenic carcinoma (MNOBC) were treated with cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) after radiation therapy. Objective responses were seen in 11 of 23 patients (48%) with a projected median survival time of 12.5 months for responding patients and patients with stable disease. Lung, liver, and cutaneous sites of involvement proved to be highly responsive; bone involvement was less responsive. CAMP is an effective combination in the treatment of MNOBC and its use in patients with less advanced disease should be explored.
Related Publications
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
October 1978,
Cancer treatment reports,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
January 1979,
Cancer clinical trials,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
April 1983,
Acta medica Okayama,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
January 1977,
Clinical bulletin,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
September 1983,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
September 1977,
Cancer treatment reviews,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
December 1976,
Cancer,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
June 1982,
International journal of radiation oncology, biology, physics,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
July 1984,
Journal of surgical oncology,
J D Bitran, and
R K Desser, and
T R DeMeester, and
M Colman, and
R Evans, and
A Billings, and
M Griem, and
L Rubenstein, and
C Shapiro, and
H M Golomb
November 1985,
Cancer,
